NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Aferna Bio

Aferna Bio

Private
Saint Louis, MichiganHealthcare & Life Scienceshttps://www.afernabio.com/

Last Round

VC Round

Jun 4, 2025

Company Overview

Aferna Bio is an agtech company that develops ribonucleic acid-based molecular tools to create beneficial crop traits by working in partnership with nature.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

agricultural biotechnologyRNA methylationepigeneticscrop trait developmentagtechgene expressionmolecular biologycrop resiliencenon-GMObiotech R&Dplant breedinggenomicsbiotech licensingsynthetic biology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Aferna Bio Comparables

Compare Aferna Bio with similar companies based on industry and business-model similarity.

Aferna Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Terrana Biosciences
88%
Decibel Bio
84%
Epicrop Technologies
81%

Aferna Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 4, 2025
SeedJan 1, 2022

Key People

Founding team and executive leadership

Jon Schmuke

President Chief Technology Officer

Executive Team

Aferna Bio Investors

Notable investors and investment history

Aferna Bio investors
InvestorRounds
BioGenerator VenturesSeed
Plaisance Capital ManagementSeed
Leaps by BayerVC Round, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 4, 2025

    $4M round with participation from Leaps by Bayer.

  • Jan 1, 2022

    Seed round raised with participation from Leaps by Bayer and BioGenerator Ventures.

Aferna Bio Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Aferna Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Aferna Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersSaint Louis, Michigan
Employee Range4
Year Founded2022
Last FundingJun 4, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.